CAR T-cell therapy has captured the attention of the public because of the remarkable responses it has produced in some patients for whom all other treatments had stopped working. We show activity of inventors and applicants, locations of inventive activity, preferred territories of patent protection and cooperation networks. Citation analysis reveals high-impact patents. Investment in manpower (inventor count) shows the commitment of patent applicants to their R&D investment in CAR T-cell therapy.
